218 related articles for article (PubMed ID: 25274482)
1. Tpl2 induces castration resistant prostate cancer progression and metastasis.
Lee HW; Cho HJ; Lee SJ; Song HJ; Cho HJ; Park MC; Seol HJ; Lee JI; Kim S; Lee HM; Choi HY; Nam DH; Joo KM
Int J Cancer; 2015 May; 136(9):2065-77. PubMed ID: 25274482
[TBL] [Abstract][Full Text] [Related]
2. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
[TBL] [Abstract][Full Text] [Related]
4. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y
Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736
[TBL] [Abstract][Full Text] [Related]
5. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
[TBL] [Abstract][Full Text] [Related]
6. TPL2/COT/MAP3K8 (TPL2) activation promotes androgen depletion-independent (ADI) prostate cancer growth.
Jeong JH; Bhatia A; Toth Z; Oh S; Inn KS; Liao CP; Roy-Burman P; Melamed J; Coetzee GA; Jung JU
PLoS One; 2011 Jan; 6(1):e16205. PubMed ID: 21267413
[TBL] [Abstract][Full Text] [Related]
7. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
[TBL] [Abstract][Full Text] [Related]
8. SPP1 Promotes Enzalutamide Resistance and Epithelial-Mesenchymal-Transition Activation in Castration-Resistant Prostate Cancer via PI3K/AKT and ERK1/2 Pathways.
Pang X; Zhang J; He X; Gu Y; Qian BZ; Xie R; Yu W; Zhang X; Li T; Shi X; Zhou Y; Cui Y
Oxid Med Cell Longev; 2021; 2021():5806602. PubMed ID: 34721759
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
10. Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer.
Stoyanova T; Riedinger M; Lin S; Faltermeier CM; Smith BA; Zhang KX; Going CC; Goldstein AS; Lee JK; Drake JM; Rice MA; Hsu EC; Nowroozizadeh B; Castor B; Orellana SY; Blum SM; Cheng D; Pienta KJ; Reiter RE; Pitteri SJ; Huang J; Witte ON
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6457-E6466. PubMed ID: 27694579
[TBL] [Abstract][Full Text] [Related]
11. ATM‑JAK‑PD‑L1 signaling pathway inhibition decreases EMT and metastasis of androgen‑independent prostate cancer.
Zhang L; Xu LJ; Zhu J; Li J; Xue BX; Gao J; Sun CY; Zang YC; Zhou YB; Yang DR; Shan YX
Mol Med Rep; 2018 May; 17(5):7045-7054. PubMed ID: 29568923
[TBL] [Abstract][Full Text] [Related]
12. Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model.
Pan HC; Lai DW; Lan KH; Shen CC; Wu SM; Chiu CS; Wang KB; Sheu ML
Carcinogenesis; 2013 Nov; 34(11):2568-79. PubMed ID: 23828905
[TBL] [Abstract][Full Text] [Related]
13. Autocrine Activation of CHRM3 Promotes Prostate Cancer Growth and Castration Resistance via CaM/CaMKK-Mediated Phosphorylation of Akt.
Wang N; Yao M; Xu J; Quan Y; Zhang K; Yang R; Gao WQ
Clin Cancer Res; 2015 Oct; 21(20):4676-85. PubMed ID: 26071486
[TBL] [Abstract][Full Text] [Related]
14. Tpl2 knockout keratinocytes have increased biomarkers for invasion and metastasis.
Decicco-Skinner KL; Jung SA; Tabib T; Gwilliam JC; Alexander H; Goodheart SE; Merchant AS; Shan M; Garber C; Wiest JS
Carcinogenesis; 2013 Dec; 34(12):2789-98. PubMed ID: 24067898
[TBL] [Abstract][Full Text] [Related]
15. HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer.
Ruscetti M; Dadashian EL; Guo W; Quach B; Mulholland DJ; Park JW; Tran LM; Kobayashi N; Bianchi-Frias D; Xing Y; Nelson PS; Wu H
Oncogene; 2016 Jul; 35(29):3781-95. PubMed ID: 26640144
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Associated Macrophage Promotes the Survival of Cancer Cells upon Docetaxel Chemotherapy via the CSF1/CSF1R-CXCL12/CXCR4 Axis in Castration-Resistant Prostate Cancer.
Guan W; Li F; Zhao Z; Zhang Z; Hu J; Zhang Y
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34069563
[TBL] [Abstract][Full Text] [Related]
17. lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5.
Gu P; Chen X; Xie R; Han J; Xie W; Wang B; Dong W; Chen C; Yang M; Jiang J; Chen Z; Huang J; Lin T
Mol Ther; 2017 Aug; 25(8):1959-1973. PubMed ID: 28487115
[TBL] [Abstract][Full Text] [Related]
18. MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity.
Wang Y; Shao N; Mao X; Zhu M; Fan W; Shen Z; Xiao R; Wang C; Bao W; Xu X; Yang C; Dong J; Yu D; Wu Y; Zhu C; Wen L; Lu X; Lu YJ; Feng N
Oncotarget; 2016 Jul; 7(30):47444-47464. PubMed ID: 27329728
[TBL] [Abstract][Full Text] [Related]
19. Cell adhesion tunes inflammatory TPL2 kinase signal transduction.
Vougioukalaki M; Georgila K; Athanasiadis EI; Eliopoulos AG
Cell Mol Life Sci; 2022 Feb; 79(3):156. PubMed ID: 35218437
[TBL] [Abstract][Full Text] [Related]
20. PRKAR2B promotes prostate cancer metastasis by activating Wnt/β-catenin and inducing epithelial-mesenchymal transition.
Sha J; Han Q; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Xue W
J Cell Biochem; 2018 Sep; 119(9):7319-7327. PubMed ID: 29761841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
